Haifeng Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Haifeng Sun has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Boyuan Ren
Beijing Institute of Radiation Medicine, Beijing 100850, China
1 shared publication - Chengqi Jia
Department of Pediatric Sports Medicine, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China
1 shared publication - Hai-Chao Yu
School of Medicine, Nankai University, Tianjin 300071, China
1 shared publication - Jie Yu
Peking Union Medical college Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
1 shared publication - Xuesong Zhang
School of Medicine, Nankai University, Tianjin, 300071, China
1 shared publication - Xuhui Zhou
Department of Orthopedics, Changzheng Hospital, Second Military Medical University (Naval Medical University), Shanghai, China
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 1 February 2024
- Published by KEAI Publishing in Bioactive Materials
- Vol. 32, 164-176
Supramolecular self-assembly of EGCG-selenomethionine nanodrug for treating osteoarthritis
Osteoarthritis (OA) has emerged as a significant health concern among the elderly population, with increasing attention paid to ferroptosis-induced OA in recent years. However, the prolonged use of nonsteroidal anti-inflammatory drugs or corticosteroids can lead to a series of side effects and limited therapeutic efficacy. This study aimed to employ the Mannich condensation reaction between epigallocatechin-3-gallate (EGCG) and selenomethionine (SeMet) to efficiently synthesize polyphenol-based nanodrugs in aqueous media for treating OA. Molecular biology experiments demonstrated that EGCG-based nanodrugs (ES NDs) could effectively reduce glutathione peroxidase 4 (GPX4) inactivation, abnormal Fe2+ accumulation, and lipid peroxidation induced by oxidative stress, which ameliorated the metabolic disorder of chondrocytes and other multiple pathological processes triggered by ferroptosis. Moreover, imaging and histopathological analysis of the destabilization of the medial meniscus model in mice confirmed that ES NDs exhibiting significant therapeutic effects in relieving OA. The intra-articular delivery of ES NDs represents a promising approach for treating OA and other joint inflammatory diseases.
- 1 February 2024
- Published by KEAI Publishing in Bioactive Materials
- Vol. 32, 164-176
Top Cited PapersOpen AccessSupramolecular self-assembly of EGCG-selenomethionine nanodrug for treating osteoarthritis
Osteoarthritis (OA) has emerged as a significant health concern among the elderly population, with increasing attention paid to ferroptosis-induced OA in recent years. However, the prolonged use of nonsteroidal anti-inflammatory drugs or corticosteroids can lead to a series of side effects and limited therapeutic efficacy. This study aimed to employ the Mannich condensation reaction between epigallocatechin-3-gallate (EGCG) and selenomethionine (SeMet) to efficiently synthesize polyphenol-based nanodrugs in aqueous media for treating OA. Molecular biology experiments demonstrated that EGCG-based nanodrugs (ES NDs) could effectively reduce glutathione peroxidase 4 (GPX4) inactivation, abnormal Fe2+ accumulation, and lipid peroxidation induced by oxidative stress, which ameliorated the metabolic disorder of chondrocytes and other multiple pathological processes triggered by ferroptosis. Moreover, imaging and histopathological analysis of the destabilization of the medial meniscus model in mice confirmed that ES NDs exhibiting significant therapeutic effects in relieving OA. The intra-articular delivery of ES NDs represents a promising approach for treating OA and other joint inflammatory diseases.